Besponsa | Inotuzumab Ozogamicin Injection

✓ Targeted CD22 antibody-drug conjugate

✓ Delivers potent cytotoxic payload directly to ALL cells

✓ High complete hematologic remission rates

✓ Bridges patients effectively to stem cell transplant

✓ Premier targeted relapsed/refractory ALL care

Guaranteed Safe Checkout

Onlinemedex Features:-

Fulfilled-using-ems

Generic Name :	Inotuzumab Ozogamicin
Drug class:	Anti-CD22 Antibody-Drug Conjugate
CSA Schedule:	Non-controlled drug
Approval:	FDA approved 2017

Reviews

There are no reviews yet.

Be the first to review “Besponsa | Inotuzumab Ozogamicin Injection”